PART-1 Polyclonal Antibody

PART1 is induced by androgen in prostate adenocarcinoma cells. Multiple alternatively transcript variants have been described for this gene, none of which are predicted to encode a protein product.

Introducing our highly efficient and reliable Polyclonal Antibody, a cutting-edge solution designed to revolutionize the field of immunology. This meticulously crafted product is meticulously developed using state-of-the-art techniques, ensuring exceptional quality and performance.

Our Polyclonal Antibody is derived from a diverse range of B cells, resulting in a broad spectrum of antibodies that target multiple epitopes. This unique characteristic allows for enhanced specificity and sensitivity, making it an invaluable tool for various applications, including immunohistochemistry, Western blotting, and flow cytometry.

With an extensive range of host species options, our Polyclonal Antibody offers unparalleled versatility, catering to the diverse needs of researchers across different fields. Its exceptional affinity and avidity enable precise and accurate detection, facilitating groundbreaking discoveries and advancements in scientific research.

Furthermore, our Polyclonal Antibody undergoes rigorous quality control measures to ensure consistent and reproducible results. Each batch is meticulously tested for specificity, sensitivity, and purity, guaranteeing optimal performance and reliability.

In addition to its exceptional performance, our Polyclonal Antibody is packaged in a user-friendly format, providing ease of use and convenience. Its long shelf life ensures prolonged usability, minimizing the need for frequent reordering and reducing overall costs.

Choose our Polyclonal Antibody and unlock the potential for groundbreaking discoveries in the field of immunology. Experience the epitome of quality, reliability, and performance with our cutting-edge product.